196
Views
6
CrossRef citations to date
0
Altmetric
Theme: Infectious Diseases - Review

Molecular methods in the diagnosis of Clostridium difficile infections: an update

, , &
Pages 681-692 | Published online: 09 Jan 2014

References

  • Jones AM, Kuijper EJ, Wilcox MH. Clostridium difficile: a European perspective. J. Infect. 66(2), 115–128 (2013).
  • Cohen SH, Gerding DN, Johnson S et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol. 31(5), 431–455 (2010).
  • Wilcox MH, Planche T, Fang FC, Gilligan P. What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J. Clin. Microbiol. 48(12), 4347–4353 (2010).
  • Peterson LR, Mehta MS, Patel PA et al. Laboratory testing for Clostridium difficile infection: light at the end of the tunnel. Am. J. Clin. Pathol. 136(3), 372–380 (2011).
  • Sharp SE, Ruden LO, Pohl JC, Hatcher PA, Jayne LM, Ivie WM. Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. J. Clin. Microbiol. 48(6), 2082–2086 (2010).
  • Surawicz CM, Brandt LJ, Binion DG et al. Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections. Am. J. Gastroenterol. 108(4), 478–498 (2013).
  • Stamper PD, Alcabasa R, Aird D et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J. Clin. Microbiol. 47(2), 373–378 (2009).
  • Eastwood K, Else P, Charlett A, Wilcox M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J. Clin. Microbiol. 47(10), 3211–3217 (2009).
  • Lalande V, Barrault L, Wadel S, Eckert C, Petit JC, Barbut F. Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections. J. Clin. Microbiol. 49(7), 2714–2716 (2011).
  • Planche T, Wilcox M. Reference assays for Clostridium difficile infection: one or two gold standards? J. Clin. Pathol. 64(1), 1–5 (2011).
  • Finegold SM. Clinical considerations in the diagnosis of antimicrobial agent-associated gastroenteritis. Diagn. Microbiol. Infect. Dis. 4(3 Suppl.), 87S–91S (1986).
  • Johal SS, Hammond J, Solomon K, James PD, Mahida YR. Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy. Gut 53(5), 673–677 (2004).
  • Dubberke ER, Han Z, Bobo L et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J. Clin. Microbiol. 49(8), 2887–2893 (2011).
  • Hink T, Burnham CA, Dubberke ER. A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens. Anaerobe 19, 39–43 (2013).
  • She RC, Durrant RJ, Petti CA. Evaluation of enzyme immunoassays to detect Clostridium difficile toxin from anaerobic stool culture. Am. J. Clin. Pathol. 131(1), 81–84 (2009).
  • Kato N, Ou CY, Kato H et al. Detection of toxigenic Clostridium difficile in stool specimens by the polymerase chain reaction. J. Infect. Dis. 167(2), 455–458 (1993).
  • Boondeekhun HS, Gurtler V, Odd ML, Wilson VA, Mayall BC. Detection of Clostridium difficile enterotoxin gene in clinical specimens by the polymerase chain reaction. J. Med. Microbiol. 38(5), 384–387 (1993).
  • Persson S, De Boer RF, Kooistra-Smid AM, Olsen KE. Five commercial DNA extraction systems tested and compared on a stool sample collection. Diagn. Microbiol. Infect. Dis. 69(3), 240–244 (2011).
  • Lyras D, O'connor JR, Howarth PM et al. Toxin B is essential for virulence of Clostridium difficile. Nature 458(7242), 1176–1179 (2009).
  • Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467(7316), 711–713 (2010).
  • Bauer MP, Notermans DW, Van Benthem BH et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377(9759), 63–73 (2011).
  • Shin BM, Kuak EY, Yoo HM et al. Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: results of a retrospective study 2000–2005. J. Med. Microbiol. 57( Pt 6), 697–701 (2008).
  • Kozak K, Elagin V, Noren T, Unemo M. Targeting the tcdA gene: is this appropriate for detection of A and/or B Clostridium difficile toxin-producing strains? J. Clin. Microbiol. 49(6), 2383, author reply 2383–2384 (2011).
  • Squire MM, Carter GP, Mackin KE et al. Novel molecular type of Clostridium difficile in neonatal pigs, Western Australia. Emerg. Infect. Dis. 19(5), 790–792 (2013).
  • Peterson LR, Manson RU, Paule SM et al. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin. Infect. Dis. 45(9), 1152–1160 (2007).
  • Barbut F, Monot M, Rousseau A et al. Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR. Eur. J. Clin. Microbiol. Infect. Dis. 30(10), 1279–1285 (2011).
  • Saunders N, Zambon M, Sharp I et al. Guidance on the development and validation of diagnostic tests that depend on nucleic acid amplification and detection. J. Clin. Virol. 56(3), 260–270 (2013).
  • Munson E, Bilbo D, Paul M, Napierala M, Hryciuk JE. Modifications of commercial toxigenic Clostridium difficile PCR resulting in improved economy and workflow efficiency. J. Clin. Microbiol. 49(6), 2279–2282 (2011).
  • Selvaraju SB, Gripka M, Estes K, Nguyen A, Jackson MA, Selvarangan R. Detection of toxigenic Clostridium difficile in pediatric stool samples: an evaluation of Quik Check Complete Antigen assay, BD GeneOhm Cdiff PCR, and ProGastro Cd PCR assays. Diagn. Microbiol. Infect. Dis. 71(3), 224–229 (2011).
  • Viala C, Le Monnier A, Maataoui N, Rousseau C, Collignon A, Poilane I. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile. J. Microbiol. Methods 90(2), 83–85 (2012).
  • Louie L, Wong H, Mubareka S, Simor AE. An Unusual Cause of False Positive Results with the BD GeneOhm Cdiff Assay. J. Clin. Microbiol. 51(4), 1348–1349 (2013).
  • Walkty A, Lagace-Wiens PR, Manickam K et al. Laboratory diagnosis of Clostridium difficile infection - Evaluation of an algorithmic approach in comparison with the illumigene assay. J. Clin. Microbiol. 51(4), 1152–1157 (2013).
  • Bruins MJ, Verbeek E, Wallinga JA, Bruijnesteijn Van Coppenraet LE, Kuijper EJ, Bloembergen P. Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection. Eur. J. Clin. Microbiol. Infect. Dis. 31(11), 3035–3039 (2012).
  • Tenover FC, Novak-Weekley S, Woods CW et al. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J. Clin. Microbiol. 48(10), 3719–3724 (2010).
  • Zidaric V, Kevorkijan BK, Oresic N, Janezic S, Rupnik M. Comparison of two commercial molecular tests for the detection of Clostridium difficile in the routine diagnostic laboratory. J. Med. Microbiol. 60( Pt 8), 1131–1136 (2011).
  • Novak-Weekley SM, Marlowe EM, Miller JM et al. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J. Clin. Microbiol. 48(3), 889–893 (2010).
  • Bacci S, Molbak K, Kjeldsen MK, Olsen KE. Binary toxin and death after Clostridium difficile infection. Emerg. Infect. Dis. 17(6), 976–982 (2011).
  • Kok J, Wang Q, Thomas LC, Gilbert GL. Presumptive identification of Clostridium difficile strain 027/NAP1/BI on Cepheid Xpert: interpret with caution. J. Clin. Microbiol. 49(10), 3719–3721 (2011).
  • Dalpke AH, Hofko M, Zorn M, Zimmermann S. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for the direct detection of Clostridium difficile in stool specimens. J. Clin. Microbiol. 51(6), 1906–1908 (2013).
  • Le Guern R, Herwegh S, Grandbastien B, Courcol R, Wallet F. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples. J. Clin. Microbiol. 50(9), 3089–3090 (2012).
  • Hicke B, Pasko C, Groves B et al. Automated detection of toxigenic Clostridium difficile in clinical samples: isothermal tcdB amplification coupled to array-based detection. J. Clin. Microbiol. 50(8), 2681–2687 (2012).
  • Buchan BW, Mackey TL, Daly JA et al. Multicenter clinical evaluation of the Portrait toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens. J. Clin. Microbiol. 50(12), 3932–3936 (2012).
  • Stamper PD, Babiker W, Alcabasa R et al. Evaluation of a new commercial TaqMan PCR assay for direct detection of the Clostridium difficile toxin B gene in clinical stool specimens. J. Clin. Microbiol. 47(12), 3846–3850 (2009).
  • Chun JY, Kim KJ, Hwang IT et al. Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene. Nucleic Acids Res. 35(6), e40 (2007).
  • Shin BM, Mun SJ, Yoo SJ, Kuak EY. Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR assays using toxigenic Clostridium difficile culture for direct detection of tcdB from stool specimens. J. Clin. Microbiol. 50(11), 3765–3767 (2012).
  • Bauer TM, Lalvani A, Fehrenbach J et al. Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA 285(3), 313–319 (2001).
  • Delaloye J, Merlani G, Petignat C et al. Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization? Eur. J. Clin. Microbiol. Infect. Dis. 23(10), 751–758 (2004).
  • Gyorke CE, Wang S, Leslie JL, Cohen SH, Solnick JV, Polage CR. Evaluation of Clostridium difficile fecal load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi tests. J. Clin. Microbiol. 51(1), 278–280 (2013).
  • Gilligan PH. Is a two-step glutamate dehyrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile? J. Clin. Microbiol. 46(4), 1523–1525 (2008).
  • Carman RJ, Wickham KN, Chen L et al. Glutamate dehydrogenase is highly conserved among Clostridium difficile ribotypes. J. Clin. Microbiol. 50(4), 1425–1426 (2012).
  • Swindells J, Brenwald N, Reading N, Oppenheim B. Evaluation of diagnostic tests for Clostridium difficile infection. J. Clin. Microbiol. 48(2), 606–608 (2010).
  • Culbreath K, Ager E, Nemeyer RJ, Kerr A, Gilligan PH. Evolution of Testing Algorithms at a University Hospital for Detection of Clostridium difficile Infections. J. Clin. Microbiol. 50(9), 3073–3076 (2012).
  • Akobeng AK. Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice. Acta Paediatr. 96(4), 487–491 (2007).
  • Bouza E, Martin A, Van Den Berg RJ, Kuijper EJ. Laboratory-acquired Clostridium difficile polymerase chain reaction ribotype 027: a new risk for laboratory workers? Clin. Infect. Dis. 47(11), 1493–1494 (2008).
  • Aronsson B, Mollby R, Nord CE. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980–1982. J. Infect. Dis. 151(3), 476–481 (1985).
  • Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin. Infect. Dis. 45(8), 992–998 (2007).
  • Alcala L, Martin A, Marin M et al. The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem? Clin. Microbiol. Infect. 18(7), E204–E213 (2012).
  • Carroll KC, Bartlett JG. Biology of Clostridium difficile: implications for epidemiology and diagnosis. Annu. Rev. Microbiol. 65, 501–521 (2011).
  • Freeman J, Bauer MP, Baines SD et al. The changing epidemiology of Clostridium difficile infections. Clin. Microbiol. Rev. 23(3), 529–549 (2010).
  • Khanna S, Pardi DS. “Community-acquired Clostridium difficile infection: an emerging entity”. Clin. Infect. Dis. 55(12), 1741–1742 (2012).
  • Dumyati G, Stevens V, Hannett GE et al. Community-associated Clostridium difficile infections, Monroe County, New York, USA. Emerg. Infect. Dis. 18(3), 392–400 (2012).
  • Leffler DA, Lamont JT. Editorial: not so nosocomial anymore: the growing threat of community-acquired Clostridium difficile. Am. J. Gastroenterol. 107(1), 96–98 (2012).
  • Shin BM, Moon SJ, Kim YS, Shin WC, Yoo HM. Characterization of cases of Clostridium difficile infection (CDI) presenting at an emergency room: molecular and clinical features differentiate community-onset hospital-associated and community-associated CDI in a tertiary care hospital. J. Clin. Microbiol. 49(6), 2161–2165 (2011).
  • Venugopal AA, Gerding DN, Johnson S. Clostridium difficile infection rates and spectrum of disease among peripartum women at one hospital from 2003 to 2007 with molecular typing analysis of recovered Clostridium difficile isolates. Am. J. Infect. Control 39(3), 206–211 (2011).
  • Kuntz JL, Yang M, Cavanaugh J, Saftlas AF, Polgreen PM. Trends in Clostridium difficile infection among peripartum women. Infect. Control Hosp. Epidemiol. 31(5), 532–534 (2010).
  • Barbut F, Mastrantonio P, Delmee M et al. Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin. Microbiol. Infect. 13(11), 1048–1057 (2007).
  • Walker AS, Eyre DW, Wyllie DH et al. Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin. Infect. Dis. 56(11), 1589–1600 (2013).
  • Walker AS, Eyre DW, Crook DW, Wilcox MH, Peto TE. Regarding “Clostridium difficile ribotype does not predict severe infection”. Clin. Infect. Dis. 56(12), 1845–6 (2013).
  • Luo RF, Banaei N. Is repeat PCR needed for diagnosis of Clostridium difficile infection? J. Clin. Microbiol. 48(10), 3738–3741 (2010).
  • Rousseau C, Lemee L, Le Monnier A, Poilane I, Pons JL, Collignon A. Prevalence and diversity of Clostridium difficile strains in infants. J. Med. Microbiol. 60( Pt 8), 1112–1118 (2011).
  • Sammons JS, Toltzis P, Zaoutis TE. Clostridium difficile Infection in Children. JAMA pediatr. 167(6), 567–573 (2013).
  • Schutze GE, Willoughby RE, Committee on Infectious D, American Academy Of P. Clostridium difficile infection in infants and children. Pediatrics 131(1), 196–200 (2013).
  • Clayton EM, Rea MC, Shanahan F et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am. J. Gastroenterol. 104(5), 1162–1169 (2009).
  • Ananthakrishnan AN, Mcginley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 57(2), 205–210 (2008).
  • Humphries RM, Uslan DZ, Rubin Z. Performance of Clostridium difficile Toxin Enzyme Immunoassay and Nucleic Acid Amplification Tests Stratified by Patient Disease Severity. J. Clin. Microbiol. 51(3), 869–873 (2013).
  • Longtin Y, Trottier S, Brochu G et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin. Infect. Dis. 56(1), 67–73 (2013).
  • Leslie JL, Cohen SH, Solnick JV, Polage CR. Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing? Eur. J. Clin. Microbiol. Infect. Dis. 31(12), 3295–3299 (2012).
  • Chapin K. Discrepancies in testing recommendations for Clostridium difficile infection: updated review favors amplification test systems. Expert Rev. Mol. Diagn. 12(3), 223–226 (2012).
  • Loman NJ, Constantinidou C, Chan JZ et al. High-throughput bacterial genome sequencing: an embarrassment of choice, a world of opportunity. Nat. Rev. Microbiol. 10(9), 599–606 (2012).
  • Didelot X, Eyre DW, Cule M et al. Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biol. 13(12), R118 (2012).
  • Ylisiurua P, Koskela M, Vainio O, Tuokko H. Comparison of antigen and two molecular methods for the detection of Clostridium difficile toxins. Scand. J. Infect. Dis. 45(1), 19–25 (2013).
  • Goldenberg SD, Dieringer T, French GL. Detection of toxigenic Clostridium difficile in diarrheal stools by rapid real-time polymerase chain reaction. Diagn. Microbiol. Infect. Dis. 67(3), 304–307 (2010).
  • Shin S, Kim M, Kim M et al. Evaluation of the Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection. Ann. Lab. Med. 32(5), 355–358 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.